Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313887582> ?p ?o ?g. }
- W4313887582 endingPage "103489" @default.
- W4313887582 startingPage "103489" @default.
- W4313887582 abstract "The beginning of the 20th decade has witnessed an increase in drug development programs for myotonic dystrophy type 1 (DM1). We have collected nearly 20 candidate drugs with accomplished preclinical and clinical phases, updating our previous drug development pipeline review with new entries and relevant milestones for pre-existing candidates. Three interventional first-in-human clinical trials got underway with distinct drug classes, namely AOC 1001 and DYNE-101 nucleic acid-based therapies, and the small molecule pitolisant, which joins the race toward market authorization with other repurposed drugs, including tideglusib, metformin, or mexiletine, already in clinical evaluation. Furthermore, newly disclosed promising preclinical data for several additional nucleic-acid therapeutic candidates and a CRISPR-based approach, as well as the advent into the pipeline of novel therapeutic programs, increase the plausibility of success in the demanding task of providing valid treatments to patients with DM1." @default.
- W4313887582 created "2023-01-10" @default.
- W4313887582 creator A5020385124 @default.
- W4313887582 creator A5087946706 @default.
- W4313887582 creator A5001664163 @default.
- W4313887582 date "2023-03-01" @default.
- W4313887582 modified "2023-10-17" @default.
- W4313887582 title "The myotonic dystrophy type 1 drug development pipeline: 2022 edition" @default.
- W4313887582 cites W1212882679 @default.
- W4313887582 cites W1879316584 @default.
- W4313887582 cites W1919521444 @default.
- W4313887582 cites W1937800286 @default.
- W4313887582 cites W1975664052 @default.
- W4313887582 cites W1983101498 @default.
- W4313887582 cites W2049146362 @default.
- W4313887582 cites W2063936397 @default.
- W4313887582 cites W2077951355 @default.
- W4313887582 cites W2088898574 @default.
- W4313887582 cites W2109436341 @default.
- W4313887582 cites W2134754044 @default.
- W4313887582 cites W2140188816 @default.
- W4313887582 cites W2191269878 @default.
- W4313887582 cites W2204860814 @default.
- W4313887582 cites W2775795482 @default.
- W4313887582 cites W2783179910 @default.
- W4313887582 cites W2809624163 @default.
- W4313887582 cites W2887455088 @default.
- W4313887582 cites W2889530657 @default.
- W4313887582 cites W2890350848 @default.
- W4313887582 cites W2903374617 @default.
- W4313887582 cites W2903626575 @default.
- W4313887582 cites W2948440285 @default.
- W4313887582 cites W2958687511 @default.
- W4313887582 cites W2964484662 @default.
- W4313887582 cites W2964749670 @default.
- W4313887582 cites W2982260895 @default.
- W4313887582 cites W3006260506 @default.
- W4313887582 cites W3014081985 @default.
- W4313887582 cites W3014758378 @default.
- W4313887582 cites W3043136848 @default.
- W4313887582 cites W3047518349 @default.
- W4313887582 cites W3085086432 @default.
- W4313887582 cites W3092025205 @default.
- W4313887582 cites W3093423776 @default.
- W4313887582 cites W3096004580 @default.
- W4313887582 cites W3097395965 @default.
- W4313887582 cites W3108540448 @default.
- W4313887582 cites W3109370673 @default.
- W4313887582 cites W3111823727 @default.
- W4313887582 cites W3118843191 @default.
- W4313887582 cites W3134738985 @default.
- W4313887582 cites W3139226099 @default.
- W4313887582 cites W3140714476 @default.
- W4313887582 cites W3150397896 @default.
- W4313887582 cites W3162767976 @default.
- W4313887582 cites W3168210481 @default.
- W4313887582 cites W3183300925 @default.
- W4313887582 cites W4206922281 @default.
- W4313887582 cites W4207017208 @default.
- W4313887582 cites W4211181520 @default.
- W4313887582 cites W4211183277 @default.
- W4313887582 cites W4220841898 @default.
- W4313887582 cites W4221001787 @default.
- W4313887582 cites W4224231440 @default.
- W4313887582 cites W4225141706 @default.
- W4313887582 cites W4226001823 @default.
- W4313887582 cites W4229055859 @default.
- W4313887582 cites W4233707882 @default.
- W4313887582 cites W4281739941 @default.
- W4313887582 cites W4282832604 @default.
- W4313887582 cites W4284691266 @default.
- W4313887582 doi "https://doi.org/10.1016/j.drudis.2023.103489" @default.
- W4313887582 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36634841" @default.
- W4313887582 hasPublicationYear "2023" @default.
- W4313887582 type Work @default.
- W4313887582 citedByCount "7" @default.
- W4313887582 countsByYear W43138875822023 @default.
- W4313887582 crossrefType "journal-article" @default.
- W4313887582 hasAuthorship W4313887582A5001664163 @default.
- W4313887582 hasAuthorship W4313887582A5020385124 @default.
- W4313887582 hasAuthorship W4313887582A5087946706 @default.
- W4313887582 hasBestOaLocation W43138875821 @default.
- W4313887582 hasConcept C126322002 @default.
- W4313887582 hasConcept C2778063965 @default.
- W4313887582 hasConcept C2780035454 @default.
- W4313887582 hasConcept C535046627 @default.
- W4313887582 hasConcept C60644358 @default.
- W4313887582 hasConcept C64903051 @default.
- W4313887582 hasConcept C71924100 @default.
- W4313887582 hasConcept C74187038 @default.
- W4313887582 hasConcept C86803240 @default.
- W4313887582 hasConcept C98274493 @default.
- W4313887582 hasConceptScore W4313887582C126322002 @default.
- W4313887582 hasConceptScore W4313887582C2778063965 @default.
- W4313887582 hasConceptScore W4313887582C2780035454 @default.
- W4313887582 hasConceptScore W4313887582C535046627 @default.
- W4313887582 hasConceptScore W4313887582C60644358 @default.
- W4313887582 hasConceptScore W4313887582C64903051 @default.